EUVIMEDEUVIMED entdecken
Crossref

Huperzine a ameliorates sepsis-induced acute lung injury by suppressing inflammation and oxidative stress via α7 nicotinic acetylcholine receptor

Jingqian Su, Kunsen Chen, Xiao Sang, Zhihua Feng, Fen Zhou, Heng Zhao, Shun Wu, Xiaohui Deng, Congfan Lin, Xinrui Lin, Lian Xie, Hui Ye und 1 weitere

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Jingqian Su und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou,…. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Acute Lung Injury, Sepsis, Oxidative Stress. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Aerospace Science Foundation of China, Science and Technology Projects of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis, characterized by high mortality rates, causes over 50 % of acute lung injury (ALI) cases, primarily due to the heightened susceptibility of the lungs during this condition. Suppression of the excessive inflammatory response is critical for improving the survival of patients with sepsis; nevertheless, no specific anti-sepsis drugs exist. Huperzine A (HupA) exhibits neuroprotective and anti-inflammatory properties; however, its underlying mechanisms and effects on sepsis-induced ALI have yet to be elucidated. In this study, we demonstrated the potential of HupA for treating sepsis and explored its mechanism of action. To investigate the in vivo impacts of HupA, a murine model of sepsis was induced through cecal ligation and puncture (CLP) in both wild-type (WT) and α7 nicotinic acetylcholine receptor (α7nAChR) knockout mice. Our results showed that HupA ameliorates sepsis-induced acute lung injury by activating the α7nAChR. We used the CLP sepsis model in wild-type and α7nAChR -/- mice and found that HupA significantly increased the survival rate through α7nAChR, reduced the pro-inflammatory cytokine levels and oxidative stress, ameliorated histopathological lung injury, altered the circulating immune cell composition, regulated gut microbiota, and promoted short-chain fatty acid production through α7nAChR in vivo. Additionally, HupA inhibited Toll-like receptor NF-κB signaling by upregulating the α7nAChR/protein kinase B/glycogen synthase kinase-3 pathways. Our data elucidate HupA's mechanism of action and support a "new use for an old drug" in treating sepsis. Our findings serve as a basis for further in vivo studies of this drug, followed by application to humans. Therefore, the findings have the potential to benefit patients with sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha7 Nicotinic Acetylcholine ReceptorAcute Lung InjurySepsisOxidative StressAlkaloidsMice, KnockoutMice, Inbred C57BLSesquiterpenesAnimalsMiceMaleAnti-Inflammatory AgentsCytokinesDisease Models, AnimalHumansLungGastrointestinal MicrobiomeInflammation

Stichwörter der Autor:innen

Acute lung injuryGut microbiotaHuperzine AInflammatory responseSepsisα7 nicotinic acetylcholine receptor

Substanzen

alpha7 Nicotinic Acetylcholine ReceptorAlkaloidshuperzine ASesquiterpenesAnti-Inflammatory AgentsCytokines

Autor:innen und Institutionen

  • Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, Fujian Province 350117, PR China. Electronic address: sjq027@fjnu.edu…
  • Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, Fujian Province 350117, PR China.
  • Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, Fujian Province 350117, PR China. Electronic address: chenqi@fjnu.edu…

Förderung

  • National Natural Science Foundation of China
  • National Aerospace Science Foundation of China
  • Science and Technology Projects of Fujian Province
  • Fujian Provincial Health Technology Project

Zitieren

APA

Su, J., Chen, K., Sang, X., Feng, Z., Zhou, F., Zhao, H., Wu, S., Deng, X., Lin, C., Lin, X., Xie, L., Ye, H., & Chen, Q. (2024). Huperzine a ameliorates sepsis-induced acute lung injury by suppressing inflammation and oxidative stress via α7 nicotinic acetylcholine receptor. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112907

Vancouver

Su J, Chen K, Sang X, Feng Z, Zhou F, Zhao H, et al. Huperzine a ameliorates sepsis-induced acute lung injury by suppressing inflammation and oxidative stress via α7 nicotinic acetylcholine receptor. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112907

BibTeX
@article{Su2024,
  author = {Su, Jingqian and Chen, Kunsen and Sang, Xiao and Feng, Zhihua and Zhou, Fen and Zhao, Heng and Wu, Shun and Deng, Xiaohui and Lin, Congfan and Lin, Xinrui and Xie, Lian and Ye, Hui and Chen, Qi},
  title = {Huperzine a ameliorates sepsis-induced acute lung injury by suppressing inflammation and oxidative stress via α7 nicotinic acetylcholine receptor},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112907}
}
Kostenlos starten →